You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百本醫護(02293.HK)年度收益約1.4億港元 同比增加約27.9%
格隆匯 09-27 21:23

格隆匯9月27日丨百本醫護(02293.HK)公吿,截至2022年6月30日止年度的收益約1.4億港元,同比增加約27.9%。公司權益持有人應占溢利約5860萬港元,同比減少約3.9%。年內公司權益持有人應占每股盈利14.66港仙。截至2022年6月30日止年度,建議末期股息為每股普通股5.00港仙(2021年:無)。

集團致力為包括香港醫院、社會服務機構及診所在內的個人及機構客户提供醫護人手解決方案服務。集團為向其登記的自僱醫護人員提供服務機會。透過由專業醫護人員組成的外展團隊,集團亦提供外展個案評估相關服務。

年內來自提供外展個案評估相關服務的收益增長約67.9%至約2820萬港元,主要可歸因於對醫療及健康評估服務(尤其是香港社區疫苗接種中心)的需求增加。

為了維持龐大而多元化的登記醫護人員規模以更好地把握髮展機遇,集團提供各種會員福利來吸引及留住向集團登記的醫護人員。於2022年6月30日,已向集團登記的醫護人員數目約有25,000名。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account